Metrovacesa S.A. (LON:0HXI)
9.04
-0.02 (-0.22%)
At close: Dec 23, 2025
Metrovacesa Revenue
Metrovacesa had revenue of 132.52M EUR in the half year ending June 30, 2025, a decrease of -18.00%. This brings the company's revenue in the last twelve months to 555.25M, down -14.49% year-over-year. In the year 2024, Metrovacesa had annual revenue of 653.07M with 12.48% growth.
Revenue (ttm)
555.25M EUR
Revenue Growth
-14.49%
P/S Ratio
2.53
Revenue / Employee
2.55M EUR
Employees
218
Market Cap
1.20B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 653.07M | 72.45M | 12.48% |
| Dec 31, 2023 | 580.62M | 64.87M | 12.58% |
| Dec 31, 2022 | 515.75M | 3.65M | 0.71% |
| Dec 31, 2021 | 512.10M | 372.26M | 266.21% |
| Dec 31, 2020 | 139.84M | -21.47M | -13.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |